These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18708360)

  • 1. Chemokine decoy receptor d6 plays a negative role in human breast cancer.
    Wu FY; Ou ZL; Feng LY; Luo JM; Wang LP; Shen ZZ; Shao ZM
    Mol Cancer Res; 2008 Aug; 6(8):1276-88. PubMed ID: 18708360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
    Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
    Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential.
    Zhuang ZG; Di GH; Shen ZZ; Ding J; Shao ZM
    Mol Cancer Res; 2006 Nov; 4(11):843-9. PubMed ID: 17114342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
    Li JY; Ou ZL; Yu SJ; Gu XL; Yang C; Chen AX; Di GH; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 Feb; 131(3):837-48. PubMed ID: 21479551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CXCL14 and its anticancer role in breast cancer.
    Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors.
    Nibbs RJ; Gilchrist DS; King V; Ferra A; Forrow S; Hunter KD; Graham GJ
    J Clin Invest; 2007 Jul; 117(7):1884-92. PubMed ID: 17607362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
    Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
    Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
    Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastasis in breast cancer xenografts is associated with increased regions of extravascular drain, lymphatic vessel area, and invasive phenotype.
    Pathak AP; Artemov D; Neeman M; Bhujwalla ZM
    Cancer Res; 2006 May; 66(10):5151-8. PubMed ID: 16707438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased inflammation in mice deficient for the chemokine decoy receptor D6.
    Martinez de la Torre Y; Locati M; Buracchi C; Dupor J; Cook DN; Bonecchi R; Nebuloni M; Rukavina D; Vago L; Vecchi A; Lira SA; Mantovani A
    Eur J Immunol; 2005 May; 35(5):1342-6. PubMed ID: 15789340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo.
    Berres ML; Trautwein C; Zaldivar MM; Schmitz P; Pauels K; Lira SA; Tacke F; Wasmuth HE
    Biol Chem; 2009 Oct; 390(10):1039-45. PubMed ID: 19642876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
    Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
    Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
    Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
    Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.
    Martinez de la Torre Y; Buracchi C; Borroni EM; Dupor J; Bonecchi R; Nebuloni M; Pasqualini F; Doni A; Lauri E; Agostinis C; Bulla R; Cook DN; Haribabu B; Meroni P; Rukavina D; Vago L; Tedesco F; Vecchi A; Lira SA; Locati M; Mantovani A
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2319-24. PubMed ID: 17283337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the chemokine scavenger receptor D6 in balancing inflammation and immune activation.
    Borroni EM; Buracchi C; Savino B; Pasqualini F; Russo RC; Nebuloni M; Bonecchi R; Mantovani A; Locati M
    Methods Enzymol; 2009; 460():231-43. PubMed ID: 19446728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: clinicopathological correlations.
    Cui LF; Guo XJ; Wei J; Liu FF; Fan Y; Lang RG; Gu F; Zhang XM; Fu L
    Histopathology; 2008 Oct; 53(4):381-8. PubMed ID: 18764880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.